Silver Castle, an investment house, agreed to merge with Israel-China Biotechnology, a collaboration platform. As part of the transaction, Silver Castle shareholders will be allotted shares that will constitute 75% of the merged company. Financial terms were not disclosed. “The move to join TASE is a significant milestone in the evolution of public awareness, as well as in the promotion and recognition of the field of digital assets in Israel. In view of the growth in the global digital currency market, we believe that the Israeli capital market is absolutely ready for digital investing. As the first dedicated crypto-investment house, we offer our clients a direct approach towards innovative investment opportunities, and can make crypto-investing accessible through our professional, experienced and valued team here in Israel," Eli Mizroch, Silver Castle CEO.